Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21

机标关键词：lung adenocarcinoma、growth factor receptor、liquid chromatography、overall survival、tyrosine kinase、point mutation、response rate

所属期刊栏目：35

分类号：R73;R96

资助基金：We thank Dr. Ning Wang, a radiologist from Radiology Department of Beijing Cancer Hospital & Institute, for his contribution to response assessment;Qianqian Song, from Novogene Company, for her contribution to biology information processing. This work was supported by grants from the National Natural Sciences Foundation Key Program81330062;Education Ministry Innovative Research Team ProgramIRT13003;Peking University-Tsinghua University Joint Center for Life Sciences Clinical Investigator, National High Technology Research and Development Program 863SS2015AA020403;Beijing Technology ProjectZ141100000214013

在线出版日期：2016-06-01（万方平台首次上网日期，不代表论文的发表时间）

页数：共10页

页码：171-180